Quantcast
Last updated on April 18, 2014 at 6:03 EDT

Latest Neurochemical Stories

2012-07-16 11:04:08

Novel system will help treat diseases like Parkinson's, Tourette's and depression Mayo Clinic researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation (DBS). The groundbreaking insight will help physicians more effectively use DBS to treat brain disorders such as Parkinson's disease, depression and Tourette syndrome. The findings are published in the journal Mayo Clinic Proceedings. Journalists: For multimedia...

2012-07-16 06:29:33

(Ivanhoe Newswire) — Parkinson's, Tourette Syndrome and Depression.  They are a debilitating disease and they also share something else in common, a surplus or deficiency of neurochemicals in the brain. Now, researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation. The research conducted by the Mayo Clinic will help physicians more effectively use DBS to treat brain disorders. "We can learn what...

2011-06-02 13:14:49

Tiny electrodes have been coated with a drug-loaded polymer in an attempt to design an implant capable of detecting a number of neurological symptoms, such as those associated with an epileptic seizure, and treating them simultaneously. In a study published today, 2 June 2011, in IOP Publishing's Journal of Neural Engineering, researchers have developed a novel technology to precisely modulate individual neurons in rats, allowing the molecular, neuronal, and circuit functions to be analysed...

890c12c327b346193e3b6665fb6f259f
2009-07-02 14:00:00

Work with tiny worm could point to new treatments for human brain disordersAlthough the tiny roundworm Caenorhabditis elegans has only 302 neurons in its entire nervous system, studies of this simple animal have significantly advanced our understanding of human brain function because it shares many genes and neurochemical signaling molecules with humans. Now MIT researchers have found novel C. elegans neurochemical receptors, the discovery of which could lead to new therapeutic targets for...

2009-06-09 12:49:19

 A research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia (PI), providing greater insight to the limited understanding of the condition's pathology.Results indicate that gamma-aminobutyric acid (GABA), the most common inhibitory transmitter in the brain, is reduced by nearly 30 percent in...